$1.33
▼ -0.8% Today
as of Oct 22, 16:49 ET
Last 30 days
Recent Press Releases & News
INM earnings at a glance
InMed Pharmaceuticals Inc. (INM) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±2.3% on average; after the most recent report on May 6, 2026 it moved -1.9%. The share price of $1.33 sits in the middle of its 52-week range.
Overview
52-week range
$0.57
$2.33
43% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-2.3%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $-0.69 | — | — | +64.4% | -1.9% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $-0.51 | — | — | — | — | financials |
| Thu Nov 6, 2025 | Sep/2025 | $-0.44 | — | — | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-1.94 | — | — | — | -2.8% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-3.64 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-2.71 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-3.58 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-3.71 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-15.24 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.60 | — | — | — | — | financials |
| Sat Dec 31, 2022 | Dec 2022 | $-0.91 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $-4.06 | — | — | — | — | financials |
| Thu Mar 31, 2022 | Mar 2022 | $-6.14 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Nov 5, 2026 | Sep/2026 | OTHER | — | -$0.44 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $820,188 | $1M | — | $1M | $1M | $1M | — |
| Cost of revenue | — | $635,994 | $716,962 | — | $1M | $650,813 | $771,225 | — |
| Gross profit | — | $184,194 | $403,159 | — | $175,625 | $460,894 | $493,413 | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $-3M | — | — | — | — | — | — | — |
| EPS (diluted) | $-0.73 | $-0.51 | $-0.44 | — | — | $-3.64 | $-2.71 | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $5M | $7M | $9M | $11M | $5M | $3M | $6M | $7M |
| Inventory | — | $947,898 | $890,807 | $961,173 | $813,970 | $1M | $1M | $1M |
| Total current assets | $7M | $9M | $11M | $13M | $6M | $5M | $7M | $9M |
| Total assets | $9M | $11M | $13M | $16M | $9M | $9M | $10M | $12M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M |
| Total equity | $7M | — | — | $13M | — | — | — | $9M |
Implied volatility — last 90 days
No IV snapshots yet for INM.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
INM earnings FAQ
When is INM's next earnings date?
InMed Pharmaceuticals Inc. is expected to report on November 5, 2026.
How does INM stock usually react to earnings?
Across the last 2 reports the average next-day move was ±2.3%, up 0 times and down 2 times.